| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Letters to the Editor |
Department of Molecular Biology, University of Medicine and Dentistry of New Jersey, Stratford, New Jersey
In Response:
We thank Franz Buchegger and coworkers for their interest in our article. They raise a valid point about the pitfalls of propidium iodide staining in fluorescence-activated cell sorting (FACS) cell cycle analysis. Fortunately, we provide a control cell line that does not show 5-fluoro-2'-deoxyuridine (FdUrd)induced turnover but does show a cell cycleinduced turnover of the nuclear isoform of uracil-DNA glycosylase (nUDG). In previous work, we show that nUDG from HeLa S3 cells turns over in a cell cycledependent manner (1). In contrast, nUDG remains stable when HeLa S3 cells are treated with FdUrd. Therefore, similar cell cycledependent mechanisms seem to exist for nUDG turnover in both HeLa S3 and HT29 cell lines. In contrast, different mechanisms seem to be at work in these cell lines in relation to FdUrd-induced nUDG instability. Both cell lines reveal nearly identical cell cycle patterns as a function of time post-FdUrd treatment. FACS analyses of both cell lines, as a function of FdUrd treatment, are shown in Fig. 2 of our recent publication (2). Taking our published results in their entirety tends to indicate that there is a distinct FdUrd-associated trigger that induces nUDG instability in certain cell lines (e.g., HT29) but not in others (e.g., HeLa S3).
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |